Promaxo

Promaxo

Private
Oakland, CaliforniaHealthcare & Life Scienceshttps://www.promaxo.com

Last Round

Early Stage

VC

Mar 30, 2026

Total Funding Raised

$57.09M

Company Overview

Promaxo is a medical technology company that offers a portable MRI system specifically designed for the diagnosis of prostate cancer, utilizing advanced multi-parametric technology for efficient monitoring and treatment.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

point-of-care MRIoffice-based MRIcompact MRIprostate biopsyimage-guided biopsylow-field MRIMedTechprostate cancer diagnosticsmedical deviceurology technologymedical capital equipmentFDA 510(k) clearanceambulatory surgery centersASCsAI medical imagingrobotic guidance system

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Promaxo Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Promaxo Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCMar 30, 2026
Early FundingMar 25, 2024
StrategicOct 4, 2023
Series B ExtensionApr 28, 2022
Series BJan 13, 2021
Series B Extension
May 21, 2020

Key People

Founding team and executive leadership

Amit Vohra

Founder, President CEO

Founding Team

Aleksandar Nacev

Chief Technology Officer

Executive Team

Barbara Nicosia

Chief Financial Officer

Executive Team

Promaxo Investors

Notable investors and investment history

InvestorRounds
Kineticos Disruptor FundSeries B Extension
Kineticos VenturesSeries B Extension
Zynext VenturesEarly Funding
Almond Tree CapitalSeries B, Series A Extension
Huami CorpSeries B, Series B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 30, 2026

    $27M raised in early stage venture capital round.

  • Mar 1, 2026

    Compact MRI platform cleared for office-based and outpatient procedures.

Promaxo Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Promaxo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Promaxo's valuation, stock price, and market status.

Firmographic Details

HeadquartersOakland, California
Employee Range56
Year Founded2016
Last FundingMar 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.